BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7861127)

  • 1. Mechanisms of formation and decomposition of hypervalent chromium metabolites in the glutathione-chromium (VI) reaction.
    Moghaddas S; Gelerinter E; Bose RN
    J Inorg Biochem; 1995 Feb; 57(2):135-46. PubMed ID: 7861127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on the mechanism of oxidation of D-galacturonic acid by hypervalent chromium.
    Mangiameli MF; González JC; García SI; Frascaroli MI; Van Doorslaer S; Salas Peregrin JM; Sala LF
    Dalton Trans; 2011 Jul; 40(26):7033-45. PubMed ID: 21629965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediates produced in the reaction of chromium(VI) with dehydroascorbate cause single-strand breaks in plasmid DNA.
    Stearns DM; Wetterhahn KE
    Chem Res Toxicol; 1997 Mar; 10(3):271-8. PubMed ID: 9084906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox and complexation chemistry of the CrVI/CrV-D-glucaric acid system.
    Mangiameli MF; González JC; Bellú S; Bertoni F; Sala LF
    Dalton Trans; 2014 Jun; 43(24):9242-54. PubMed ID: 24816781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox Conversion of Chromium(VI) and Arsenic(III) with the Intermediates of Chromium(V) and Arsenic(IV) via AuPd/CNTs Electrocatalysis in Acid Aqueous Solution.
    Sun M; Zhang G; Qin Y; Cao M; Liu Y; Li J; Qu J; Liu H
    Environ Sci Technol; 2015 Aug; 49(15):9289-97. PubMed ID: 26154110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and reactivity of a chromium(v) glutathione complex.
    Levina A; Zhang L; Lay PA
    Inorg Chem; 2003 Feb; 42(3):767-84. PubMed ID: 12562191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Cr(IV)-GSH, its identification and its free hydroxyl radical generation: a model compound for Cr(VI) carcinogenicity.
    Liu KJ; Shi X; Dalal NS
    Biochem Biophys Res Commun; 1997 Jun; 235(1):54-8. PubMed ID: 9196034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structures of chromium(VI) complexes with glutathione and model thiols.
    Levina A; Lay PA
    Inorg Chem; 2004 Jan; 43(1):324-35. PubMed ID: 14704084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox and complexation chemistry of the Cr(VI)/Cr(V)/Cr(IV)-D-glucuronic acid system.
    González JC; García S; Bellú S; Salas Peregrín JM; Atria AM; Sala LF; Signorella S
    Dalton Trans; 2010 Mar; 39(9):2204-17. PubMed ID: 20162193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxochromium(V) species formed with 2,3-dehydro-2-deoxy-N-acetylneuraminic or N-acetylneuraminic (sialic) acids: an in vitro model system of oxochromium(V) species potentially stabilized in the respiratory tract upon inhalation of carcinogenic chromium(VI) compounds.
    Codd R; Lay PA
    Chem Res Toxicol; 2003 Jul; 16(7):881-92. PubMed ID: 12870891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially deadly carcinogenic chromium redox cycle involving peroxochromium(IV) and glutathione.
    Marin R; Ahuja Y; Bose RN
    J Am Chem Soc; 2010 Aug; 132(31):10617-9. PubMed ID: 20681676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes.
    Headlam HA; Lay PA
    J Inorg Biochem; 2016 Sep; 162():227-237. PubMed ID: 27365280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of a chromium(V) cis-dioxo bis(1,10-phenanthroline) complex and crystal and molecular structures of its chromium(III) precursor.
    Weeks CL; Levina A; Dillon CT; Turner P; Fenton RR; Lay PA
    Inorg Chem; 2004 Nov; 43(24):7844-56. PubMed ID: 15554650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and mechanism of the reduction of CrVI and CrV by D-lactobionic acid.
    Roldán V; Santoro M; González JC; Salas-Peregrin JM; Signorella S; Sala LF
    J Inorg Biochem; 2004 Feb; 98(2):347-57. PubMed ID: 14729315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium(VI) reduction by hydrogen sulfide in aqueous media: stoichiometry and kinetics.
    Kim C; Zhou Q; Deng B; Thornton EC; Xu H
    Environ Sci Technol; 2001 Jun; 35(11):2219-25. PubMed ID: 11414022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cr(IV) causes activation of nuclear transcription factor-kappa B, DNA strand breaks and dG hydroxylation via free radical reactions.
    Shi X; Ding M; Ye J; Wang S; Leonard SS; Zang L; Castranova V; Vallyathan V; Chiu A; Dalal N; Liu K
    J Inorg Biochem; 1999 May; 75(1):37-44. PubMed ID: 10402675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of reactive oxygen species and DNA strand breakage during interaction of chromium (III) and hydrogen peroxide in vitro: evidence for a chromium (III)-mediated Fenton-like reaction.
    Tsou TC; Yang JL
    Chem Biol Interact; 1996 Dec; 102(3):133-53. PubMed ID: 9021167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium(VI)-derived species: implications for chromium carcinogenesis.
    Molyneux MJ; Davies MJ
    Carcinogenesis; 1995 Apr; 16(4):875-82. PubMed ID: 7537182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dinuclear chromium(V) amino acid complexes from the reduction of chromium(VI) in the presence of amino acid ligands: XAFS characterization of a chromium(V) amino acid complex.
    Headlam HA; Weeks CL; Turner P; Hambley TW; Lay PA
    Inorg Chem; 2001 Sep; 40(20):5097-105. PubMed ID: 11559066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.